| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EXPNEUROL.2008.01.019 |
| P698 | PubMed publication ID | 18321484 |
| P50 | author | Mahmoud M. Iravani | Q42936283 |
| P2093 | author name string | M J Jackson | |
| P Jenner | |||
| S Rose | |||
| D J Virley | |||
| K A Stockwell | |||
| M Perren | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dyskinesia | Q629444 |
| P304 | page(s) | 172-179 | |
| P577 | publication date | 2008-02-09 | |
| P1433 | published in | Experimental Neurology | Q5421127 |
| P1476 | title | Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets | |
| P478 | volume | 211 |
| Q38155480 | Animal models of Parkinson's disease: a gateway to therapeutics? |
| Q35589979 | Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. |
| Q60950134 | Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson's Disease |
| Q48042592 | Development and uniform evaluation of ropinirole osmotic pump tablets with REQUIP XL both in vitro and in beagle dogs |
| Q38169202 | Dopamine receptor agonists for Parkinson's disease. |
| Q37685666 | From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease |
| Q37267316 | Initiation of Parkinson's disease treatment |
| Q35109436 | Long-acting versus standard non-ergot dopamine agonists in Parkinson's disease: a meta-analysis of randomized controlled trials |
| Q41105821 | Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson's disease. |
| Q37973462 | Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson's disease |
| Q39229450 | Non-human primate models of PD to test novel therapies |
| Q30538394 | Parallel dopamine D1 receptor activity dependence of l-Dopa-induced normal movement and dyskinesia in mice |
| Q43182160 | Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets |
| Q48537131 | Preparation of Rotigotine-Loaded Microspheres and Their Combination Use with L-DOPA to Modify Dyskinesias in 6-OHDA-Lesioned Rats |
| Q36680671 | Serotonin hyperinnervation and upregulated 5-HT2A receptor expression and motor-stimulating function in nigrostriatal dopamine-deficient Pitx3 mutant mice |
| Q37677200 | The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson's disease |
| Q28266116 | Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease |
| Q38127956 | Wearing Off, Dyskinesia, and the Use of Continuous Drug Delivery in Parkinson's Disease |
Search more.